Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in SMMT — Summit Therapeutics Inc.

CIK 80255 BALTIMORE, MD
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$56,732,957
-$100,215,249 QoQ
Shares Held
3,893,820
-53.0% QoQ
Ownership
0.488%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#9
of 242 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. SMMT ranks #65 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in SMMT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $56,732,957 3,893,820
2026-03-31 $156,948,206 8,277,859
2025-12-31 $163,906,048 9,371,415
2025-09-30 $93,772,083 4,538,823
2025-06-30 $83,101,548 3,905,148
2025-03-31 $126,500,038 6,557,804
2024-12-31 $117,026,206 6,557,927
2024-09-30 $119,128,487 5,439,657
2024-06-30 $15,928,379 2,042,100
2024-03-31 $137,220 33,145
2023-12-31 $73,095 28,006
2023-09-30 $50,390 26,947
2023-06-30 $59,015 23,512